NEWS

A Personal Message from CINP President, Gabriella Gobbi:

When I was a medical student in Rome in the late 1980s, I had the opportunity to explore the archives of Santa Maria della Pietà, one of Rome’s historic psychiatric hospitals, during the years in which Italy was dismantling its psychiatric hospital system following the Basaglia Law.

I remember reading clinical records from the 1950s and 1960s.

There was Lucia, a young mother who developed severe psychosis after giving birth. She was separated from her newborn child and spent much of the rest of her life in the institution.

There was Renzo, a young man who developed what we would today recognize as bipolar disorder. He, too, was admitted to an asylum.

Years of institutionalization made returning to an independ

ent life extraordinarily difficult.

Their stories have remained with me throughout my career.

Today, their lives could be very different.

A woman experiencing postpartum psychosis can receive effective treatment, recover and live with her family. A person with bipolar disorder can receive treatment, pursue a career, build a family and live a rich and fulfilling life.

This progress did not happen by chance.

It came from decades of research in neuroscience, psychopharmacology, clinical research, psychotherapy, neuromodulation, epidemiology and brain imaging.

Research has also helped us achieve something fundamental: challenging the stigma surrounding mental illness.

But our work is far from finished.

Too many people still do not respond adequately to availabl

e treatments. Too many lives are still lost to suicide. Stigma and discrimination remain. And access to high-quality mental health care is still profoundly unequal around the world.

This is why we must continue.

At CINP, scientists and clinicians from across the world work together to understand mental disorders, discover new treatments, improve existing therapies, educate the next generation and challenge stigma.

On this World Mental Health Day, let us remember how far we have come—and how much further we must go.

Mental health research saves lives.

Together, CINP is working to advance brain and mental health around the world.

CINP invites you to join TMS Intercontinental Day: a unique international programme exploring the development, current practice and future potential of transcranial magnetic stimulation.  It is a free online event open to everyone. In this short video, Professor Stefano Pallanti, Chair of the CINP Neuromodulation Global Networking Community, introduces the event and explains why this is such an important moment for the international TMS community. TMS Intercontinental Day exemplifies CINP’s mission: bringing together the global community of clinicians, researchers, patients and others with an interest in advancing brain health, enabling knowledge and experience to be shared across disciplines, countries and continents.  Throughout the day, pioneers and leading experts from five continents will examine:  The current position of TMS in different regions, including regulation, reimbursement and integration into clinical practice  The contributions made by research groups around the world  Cutting-edge research and emerging directions for TMS  Opportunities to strengthen international exchange and collaboration   The programme brings together an exceptional faculty:  Mohammed Khamis Al-Balushi · Jean-Marie Batail · Joan Camprodon-Gimenez · Salvador Dura-Bernal · Bernardo Dell’Osso · Paul Fitzgerald · Mark George · Shih Ee Goh · Ian Hickie · Risto Ilmoniemi · Siegfried Kasper · Sarah “Holly” Lisanby · Nikos Makris · Giovanni Martinotti · Shinichiro Luke Nakajima · Stefano Pallanti · Alessandro Sarzetto · Enrico Smeraldi · Joseph Taylor · Phern-Chern Tor · Leigh van den Heuvel · Fidel Vila-Rodriguez  Whether you are already working with TMS, conducting research in the field or interested in its expanding role in clinical care, this event offers a rare opportunity to hear a truly international range of perspectives. All participants will receive a certificate of attendance following the event. Join colleagues from around the world on 7 October.

As CINP seeks to communicate more regularly with its members around the world, we want to reflect not only the activities of the College, but also the important issues that unite us as an international scientific and clinical community. World Suicide Prevention Day provides a particularly meaningful occasion to do so.   I would therefore like to share the following message, together with a short video, reaffirming CINP’s commitment to advancing the research, understanding and care that can help prevent suicide and save lives. I would also like to thank the many CINP members working in this vital field, including some of the world’s most renowned suicide researchers, for their outstanding contribution to our understanding and prevention of suicide.

CINP President Gabriella Gobbi speaks on the World Suicide Prevention Day 2026

Today, on World Suicide Prevention Day, CINP joins the global community in “Changing the Narrative on Suicide.” Every hour, more than 80 people around the world die by suicide. Suicide remains one of the leading causes of death among young people worldwide. But behind these numbers are people, families, and communities. The impact of suicide reaches far beyond the individual, leaving a deep and lasting mark on partners, parents, children, siblings, friends, colleagues, and loved ones—sometimes across generations. Today, CINP stands with people experiencing suicidal thoughts and behaviours, with those who have survived a suicidal crisis, and with families and loved ones who have experienced the devastating loss of someone they love. Suicidal behaviour is complex. It is not simply an impulsive act or a single moment. It often emerges along a trajectory that may begin months or even years earlier, shaped by the interaction of psychological, social, environmental, and biological factors, including genetic vulnerability. It is frequently associated with mental health conditions, including major depression, bipolar disorder, substance use disorders, PTSD, and schizophrenia, while many other individual and societal factors can also contribute to suicide risk. As an international scientific community, CINP is deeply committed to advancing mental health research, improving prevention and care, challenging stigma, and bringing hope and empathy to people living with mental illness and suicidal behaviour. Every scientific advance can help us better understand the mental health conditions associated with suicide, develop more effective treatments, strengthen suicide prevention, replace stigma with understanding, and ultimately save lives. Mental health research saves lives. Let us advance the research that can prevent suicide. Let us start the conversation.

Gabriella Gobbi, MD, PhD President, CINP

It has already been a few weeks since the CINP community came together in Glasgow for four memorable days of science, exchange, collaboration and connection.

The official CINP 2026 Photo Gallery is now online, capturing many of the people and moments that made the congress so special – from scientific sessions and lively discussions to reunions, new connections and shared celebrations.

We invite you to browse the gallery, find yourself and your colleagues, and revisit some of your favourite memories from Glasgow.

And if you were not able to join us this time, we hope the photographs offer a glimpse of the CINP community – and perhaps some inspiration to be part of the next CINP Congress.

Visit the Gallery

If you were unable to attend our recent webinar, the recording is now available to watch on the CINP website and YouTube channel.

"Psilocybin in Depression: Insights From Contemporary Clinical Trials" features Dr. Joshua D. Rosenblat and Dr. Danica Johnson (University of Toronto & University Health Network, Canada), who provide a comprehensive overview of the latest clinical trial evidence on psilocybin for depression.

The webinar explores current findings on efficacy and safety, the regulatory and ethical frameworks underpinning clinical research, and the emerging challenges and opportunities that continue to shape this field.

Watch the recording at your convenience and stay up to date with developments in neuropsychopharmacology.

https://youtu.be/a8xpk6RR2S8?si=AADpIIO0HuTjDrXb

In June, CINP was proud to be represented at the African College of Neuropsychopharmacology (AfCNP) School on Precision Neuropsychopharmacology and Brain Health, held at the Aga Khan University Centre in Nairobi, Kenya.

Prof. Joseph Zohar, Chair of the CINP Education Committee, delivered the Dan Stein Memorial Lecture, entitled NbN and Precision in the Treatment of Psychiatric Disorders, sharing insights into precision approaches that continue to shape the future of neuropsychopharmacology.

The AfCNP School brought together clinicians, researchers, and early career professionals for an outstanding programme dedicated to scientific exchange, education, and collaboration. Events such as these play a vital role in strengthening international partnerships and advancing better brain and mental health care across the globe.

We thank our colleagues at AfCNP for their warm hospitality and for organizing such an inspiring educational initiative. CINP looks forward to continuing our collaboration in support of excellence in science, education, and patient care worldwide.

We are pleased to congratulate the newly elected officers and councillors, who will officially assume their roles during the CINP 2026 Congress.

• President Elect 2026–2028
  Gregers Wegener
• Vice-President 2026–2030
  Ming-Chyi Huang
• Treasurer 2026–2030
  Lucie Bartova
• Councillors 2026–2030
  Hilary Blumberg
  Kim Q. Do
  Cheng-Ta Li
  Julio Licinio
  Atsumi Nitta

We warmly congratulate all those elected and look forward to their leadership and contributions to the global CINP community in the years ahead.

We would also like to sincerely thank all candidates who stood in this election for their commitment, engagement, and willingness to serve CINP and the field of neuropsychopharmacology.

Wiew New Officers' Profiles

We are excited to announce the recipients of the Rafaelsen Young Investigators Award 2026:

• Benson Ku, USA
• Martin Osugo, UK
• Anjali Sankar, Denmark

Due to a very high number of entries of exceptional quality, the following applicants have been awarded a President's Recognition for Young Investigators diploma:

• Shokouh Arjmand, Denmark
• Dibyadeep Datta, USA
• Vivian Marcela Garzon Rubiano, Colombia
• Martha Lopez-Canul, Canada
• Chiara Montemitro, Italy
• Devon Stoliker, Australia
• Biju Viswanath, India

Congratulations to all awardees!

All Details About Awards

We are pleased to share a new Genomic Press Interview with Dr. Gabriella Gobbi, CINP President Elect, Professor of Psychiatry at McGill University, and Canada Research Chair in Therapeutics for Mental Health.

From pioneering research on adolescent cannabis exposure and depression, to advancing novel melatonin receptor therapeutics, and early work on the neurobiology of psychedelics - Dr. Gobbi’s career exemplifies truly translational science.

As the first woman elected CINP President in its 70-year history, she reflects on her journey from Italy to Canada, the clinical insights that shaped her research, and her vision for a neuropsychopharmacology that remains deeply connected to patient care.

Read the full interview

We are delighted to announce the recipients of the CINP Student Encouragement Award 2026:

• Giuseppe De Simone, Italy
• Carina Donegan, New Zealand
• Wenjie Hou, China
• Federica Iannotta, Italy
• Talah Khoury, Slovakia
• Takatoshi Sakata, Japan
• Asilay Seker, United Kingdom
• Nicoleta Sirbu, United Kingdom
• Angel Yonehara, Australia
• Maia Zilberman, Canada

The CINP Fellowship and Awards Committee decided to also award several President's Special Commendation Diplomas to appreciate the high quality of the received applications.

View All Details

Congratulations to all awardees!